Primary Care Updates Pharmacology CE Series

Primary Care Updates Pharmacology CE Series

Register Here

SAVE 24%! Fulfill your pharmacology CE requirement, earning 19.50 CE for Nurse Practitioners and 18.50 pharmacology credits with this package from NPACE. Important primary care topics are included in this 14-course package, addressing emerging infectious disease, hypertension management, diabetic clinical trials, new-drug update, asthma/COPD, and more.


View all courses included in this bundle below:

Safe Opioid Prescribing: How, When and When NOT to Prescribe

This program discusses pain from a contextual perspective, patient selection and assessment of risk associated with opioid use for long-term management of chronic pain, the initiation and modification of ER/ LA therapy, ongoing monitoring, and patient and caregiver education. 


Sexual Health: It’s More than STIs

Participants completing this module will have a better understanding of the importance of conducting a sexual health history and will learn tools that can be implemented into their practice setting. 


Updates on the Treatment of Blood Cholesterol

This program evaluates current evidence-based guidelines for blood cholesterol management and analysis their utility in clinical case studies.


Research in Diabetic Clinical Trials: Cardiovascular Outcome Trials and Case Presentations

This course will look at the history of Cardio-Vascular Outcome Trials: why we do them and the data we have learned from them. Specifically, these trials even though they are formally established as necessary safety trials now show reductions in cardiovascular death, non-fatal MI, and non-fatal stroke. 


Emerging Infectious Disease: A Discussion of New and Upcoming Infections

This session will provide the nurse practitioner and physician assistant with information regarding emerging trends in infectious disease. A look at the management of common viral and bacterial infections including: MRSA, Influenza, Pertussis, Ebola, Enterovirus, Lyme Disease, Herpes Simplex and more. 


Updates on Hypertension Management: Guidelines and Protocols

This presentation reviews contemporary evidenced-based guidelines for hypertension management and applies them in a variety of case studies.


This program evaluates challenging cases of anxiety, differentiates from other anxiety-producing disorders, and considers primary care management vs. psychiatry referral.


Pneumonia, ABRS, AECB, and AOM are commonly encountered respiratory conditions in the pediatric and adult patient. The latest in treatment options for individuals with these conditions will be discussed in detail.


This program presents evidence-based best practice management of asthma and COPD, using a case-study approach to illustrate application of guidelines. Current issues in pharmacotherapy are highlighted, including indications, adverse effects, and safety issues.


This program presents the mechanisms of action for all commonly used antibiotic therapy, and utilizes this information in the selection of best-practices monotherapy and combination therapy. Case studies from both primary and acute care settings are used to illustrate application.


Insomnia affects more than 60 million Americans with more than 6% of the population affected by chronic insomnia. This lecture will provide the learner with simple questions to identify and diagnose insomnia along with the various pharmacologic agents available to treat this condition. 


Keeping up with new medications, particularly given the recent trend towards direct to consumer advertising, is one of the true challenges of primary care. Ms. Wright will focus on the top new, widely used medications, including their appropriate uses, adverse effects and drug interactions.


Diabetes is a multi-faceted disease with serious complications arising from untreated or inadequately treated diabetes. Treatment often requires a multitude of nonpharmacologic and pharmacologic options as well as multitude of healthcare professionals. This seminar will focus on the latest diagnostic and treatment options.


What’s New with AHA/ACC Guidelines for the Management of Lipid Disorders?

Coronary heart disease is the number one killer of men and women in this country. Many of these individuals have abnormal lipid profiles. The purpose of this lecture is to educate the Advanced Practice Clinician regarding the risks associated with hyperlipidemia and discuss the various treatment options.